Mukaiyama–Michael Reactions between Furans and Enones or Oxo Esters
(75 MHz, CDCl3): major: δ = 209.6 (Cq, C=O), 172.2 (Cq, O– 5-(2,2-Dimethyl-5-oxocyclohexyl)furan-2(5H)-one (3g): This com-
C=O), 152.9 (CH, CH=CH–CO), 123.2 (CH, CH=CH–CO), 89.3 pound was prepared according to the General Procedure A from
(CH, CHO), 47.8 (CH2), 42.3 (Cq, CCH3), 40.5 (CH2), 32.7 (CH2),
21.2 (CH2), 20.1 (CH3) ppm; minor: δ = 209.7 (Cq, C=O), 172.3
(Cq, O–C=O), 152.8 (CH, CH=CH–CO), 123.1 (CH, CH=CH–
4,4-dimethylcyclohex-2-en-1-one (2g, 0.1 mL, 0.737 mmol) and 2-
(trimethylsilyloxy)furan (1a, 0.16 mL, 0.96 mmol) in the presence
of tin(IV) chloride solution (1 in DCM, 0.076 mL, 0.076 mmol)
CO), 88.7 (CH, CHO), 49.9 (CH2), 42.2 (Cq, CCH3), 31.0 (CH2), in DCM (3.8 mL). The crude mixture was purified through silica
21.1 (CH2) ppm; other signals masked by major isomer. IR (film):
˜
[M + Na]. HRMS: calcd. for C11H14NaO3 217.0840; found (21.1 mg, 18%). H NMR (300 MHz, CDCl3, ratio 77:23): major:
gel (heptane to heptane/EtOAc, 5:5) to afford 3g as a white solid
ν = 3100, 2950, 1742, 1697 cm–1. MS (ESI+): m/z (%) = 217 (100)
(95.2 mg, 62%) and the 1,2-addition product as a colorless oil
1
217.0841. M.p. 89–92 °C (major diastereomer).
δ = 7.47 (dd, J = 1.5, 5.8 Hz, 1 H, CH=CH–CO), 6.12 (dd, J =
2.1, 5.8 Hz, 1 H, CH=CH–CO), 5.12 (m, 1 H, CHO), 2.46–2.36
(m, 1 H), 2.35–2.29 (m, 1 H), 2.28–2.21 (m, 1 H), 2.20–2.11 (m, 2
H), 1.73 (m, 2 H), 1.20 (s, 6 H, 2ϫCH3) ppm; minor: δ = 7.30 (dd,
J = 1.6, 5.7 Hz, 1 H, CH=CH–CO), 6.10 (dd, J = 2.1, 5.7 Hz, 1
H, CH=CH–CO), 5.32 (m, 1 H, CHO), 2.00–1.86 (m, 2 H), 1.77
(m, 1 H), 1.58 (m, 1 H), 1.17 (s, 3 H, CH3), 1.16 (s, 3 H, CH3)
ppm, other signals masked by the major isomer. 13C NMR
(75 MHz, CDCl3): major: δ = 209.0 (Cq, C=O), 171.9 (Cq, O–
C=O), 154.4 (CH, CH=CH–CO), 122.8 (CH, CH=CH–CO), 83.4
(CH, CHO), 48.9 (CH, CHCHO), 40.4 (CH2), 38.8 (CH2), 37.5
(CH2), 32.4 [Cq, C(CH3)2], 29.5 (CH3), 20.9 (CH3) ppm; minor: δ
= 209.8 (Cq, C=O), 172.7 (Cq, O–C=O), 156.0 (CH, CH=CH–
CO), 122.1 (CH, CH=CH–CO), 81.7 (CH, CHO), 48.0 (CH,
CHCHO), 39.8 (CH2), 37.7 (CH2), 35.6 (CH2), 32.8 [Cq,
5-(1,3,3-Trimethyl-5-oxocyclohexyl)furan-2(5H)-one (3e): This com-
pound was prepared according to the General Procedure A from
isophorone (2e, 70 mg, 0.506 mmol) and 2-(tert-butyldimethylsilyl-
oxy)furan (1b, 130 mg, 0.66 mmol) in the presence of tin(IV) chlo-
ride solution (1 in DCM, 0.1 mL, 0.1 mmol) in DCM (2.5 mL).
The crude mixture was purified through silica gel (heptane to hep-
tane/EtOAc, 6:4) to afford a colorless oil (46.3 mg, 42%). 1H NMR
(300 MHz, CDCl3, ratio 88:12): major: δ = 7.45 (dd, J = 1.6,
6.0 Hz, 1 H, CH=CH–CO), 6.20 (dd, J = 2.1, 5.9 Hz, 1 H,
CH=CH–CO), 4.78 (dd, J = 1.7, 2.0 Hz, 1 H, CHO), 2.30 (d, J =
12.9 Hz, 1 H), 2.25 (d, J = 12.3 Hz, 1 H), 2.14 (dt, J = 13.7, 1.7 Hz,
1 H), 2.02 (dt, J = 13.7, 1.7 Hz, 1 H), 1.95 (d, J = 14.2 Hz, 1 H),
1.51 (dt, J = 14.2, 1.7 Hz, 1 H), 1.09 (s, 3 H, CH3), 1.05 (s, 3 H,
CH3), 1.04 (s, 3 H, CH3) ppm; minor: δ = 7.43 (dd, J = 1.5, 5.8 Hz,
1 H, CH=CH–CO), 6.20 (dd, J = 2.0, 5.9 Hz, 1 H, CH=CH–CO),
4.70 (dd, J = 1.7, 2.0 Hz, 1 H, CHO), 2.62 (d, J = 13.5 Hz, 1 H),
1.66 (d, J = 14.2 Hz, 1 H), 1.31 (dt, J = 12.3, 1.5 Hz, 1 H), 1.07 (s,
3 H, CH3), 1.01 (s, 3 H, CH3) ppm; other signals masked by the
major isomer. 13C NMR (75 MHz, CDCl3): major: δ = 210.0 (Cq,
C=O), 172.3 (Cq, O–C=O), 152.8 (CH, CH=CH–CO), 123.5 (CH,
CH=CH–CO), 89.8 (CH, CHO), 53.5 (CH2), 47.1 (CH2), 47.8
(CH2), 42.2 (Cq, CCH3), 35.5 [Cq, C(CH3)2], 33.7 (CH3), 29.1
(CH3), 22.5 (CH3) ppm; minor: δ = 172.4 (Cq, O–C=O), 152.9
(CH, CH=CH–CO), 123.5 (CH, CH=CH–CO), 53.7 (CH2), 48.9
(CH2), 43.4 (CH2), 41.9 (Cq, CCH3), 35.4 [Cq, C(CH3)2], 33.3
(CH3), 29.2 (CH3), 23.3 (CH3) ppm; other signals masked by the
C(CH ) ], 28.7 (CH ), 21.7 (CH ) ppm. IR (film): ν = 3117, 2950,
˜
3 2
3
3
1748, 1733, 1702 cm–1. MS (ESI+): m/z (%) = 231 (100) [M + Na].
HRMS: calcd. for C12H16NaO3 231.0997; found 231.0986. 1,2-Ad-
dition product 5-(1-hydroxy-4,4-dimethylcyclohex-2-enyl)furan-
1
2(5H)-one: H NMR (300 MHz, CDCl3, ratio 53:47): δ = 7.49 (m,
1 H maj + 1 H min, CH=CH–CO), 6.19 (m, 1 H maj + 1 H min,
CH=CH–CO), 5.74 (m, 1 H min, CH=CH), 5.70 (m, 1 H maj,
CH=CH), 5.50 (dd, J = 10.1, 1.4 Hz, 1 H maj, CH=CH), 5.41 (d,
J = 10 Hz, 1 H min, CH=CH), 4.96 (dd, J = 1.8, 1.7 Hz, 1 H min,
CHO), 4.92 (dd, J = 1.8, 1.7 Hz, 1 H maj, CHO), 2.09 (br. s, 1 H
maj + 1 H min, OH), 1.91–1.77 (m, 2 H), 1.74–1.60 (m, 4 H), 1.55–
1.44 (m, 2 H), 1.03 (s, 3 H maj + 3 H min, CH3), 0.97 (s, 3H min,
CH3), 0.95 (s, 3 H maj, CH3) ppm. 13C NMR (75 MHz, CDCl3):
major: δ = 172.9 (Cq, O–C=O), 153.2 (CH, CH=CH–CO), 144.3
(CH, CH=CH), 123.9 (CH, CH=CH), 123.1 (CH, CH=CH–CO),
88.6 (CH, CHO), 70.4 (Cq, COH), 32.4 (CH2), 32.0 [Cq,
C(CH3)2], 29.8 (CH3), 29.3 (CH2), 26.9 (CH3) ppm; minor: δ =
172.9 (Cq, O–C=O), 153.6 (CH, CH=CH–CO), 144.0 (CH,
CH=CH), 124.6 (CH, CH=CH), 122.9 (CH, CH=CH–CO), 87.5
(CH, CHO), 70.7 (Cq, COH), 32.7 (CH2), 32.0 [Cq, C(CH3)2], 29.4
major isomer. IR (film): ν = 3092, 2956, 1748, 1707 cm–1. MS
˜
(ESI+): m/z (%) = 245 (100) [M + Na]. HRMS: calcd. for
C13H18NaO3 245.1154; found 245.1155.
5-(1-Ethyl-3-oxocyclohexyl)furan-2(5H)-one (3f): This compound
was prepared according to the General Procedure A from 3-ethyl-
cyclohex-2-en-1-one (2f, 70 mg, 0.564 mmol) and 2-(tert-butyldi-
methylsilyloxy)furan (1b, 145 mg, 0.733 mmol) in the presence of
tin(IV) chloride solution (1 in DCM, 0.11 mL, 0.11 mmol) in
DCM (2.8 mL). The crude mixture was purified through silica gel
(heptane to heptane/EtOAc, 6:4) to afford a colorless oil (62.4 mg,
53%). 1H NMR (300 MHz, CDCl3, ratio 88:12): major: δ = 7.46
(dd, J = 1.4, 5.8 Hz, 1 H, CH=CH–CO), 6.16 (dd, J = 2.1, 5.9 Hz,
1 H, CH=CH–CO), 4.95 (dd, J = 1.6, 2.0 Hz, 1 H, CHO), 2.28 (m,
2 H), 2.20 (m, 1 H), 2.02 (m, 5 H), 1.50 (m, 1 H), 1.36 (m, 1 H),
0.91 (t, J = 7.5 Hz, 3 H, CH2CH3) ppm; minor: δ = 7.50 (dd, J =
1.5, 5.8 Hz, 1 H, CH=CH–CO), 6.18 (m, 1 H, CH=CH–CO), 4.91
(dd, J = 1.8, 1.9 Hz, 1 H, CHO), 0.89 (t, J = 7.6 Hz, 3 H, CH2CH3)
ppm; other signals masked by the major isomer. 13C NMR
(75 MHz, CDCl3): major: δ = 210.2 (Cq, C=O), 172.5 (Cq, O–
C=O), 153.2 (CH, CH=CH–CO), 123.2 (CH, CH=CH–CO), 87.2
(CH, CHO), 46.3 (CH2), 44.8 (Cq, CCH2CH3), 40.6 (CH2), 29.1
(CH2), 26.9 (CH2), 20.9 (CH2), 7.65 (CH3, CH2CH3) ppm; minor:
(CH ), 29.3 (CH ), 27.8 (CH ) ppm. IR (film): ν = 3439, 2954,
˜
3
2
3
1738 cm–1. MS (ESI+): m/z (%) = 231 (100) [M + Na]. HRMS:
calcd. for C12H16NaO3 231.0997; found 231.1002.
Methyl 2-Oxo-6-(5-oxo-2,5-dihydrofuran-2-yl)cyclohexanecarboxyl-
ate (5a): This compound was prepared as described in General Pro-
cedure B from methyl 6-oxocyclohex-1-enecarboxylate (4a, 60 mg,
0.384 mmol) in DCM (0.8 mL) and 2-(trimethylsilyloxy)furan (1a,
76 µL, 0.461 mmol) in the presence of copper(II) triflate (13.7 mg,
0.038 mmol) in DCM (1.4 mL). The crude mixture was purified
through silica gel (heptane to heptane/EtOAc, 6:4) to afford a col-
orless oil (76.4 mg, 83%). IR (film): ν = 2950, 1743, 1711 cm–1. MS
˜
(ESI+): m/z (%) = 261 (100) [M + Na]. HRMS: calcd. for
C12H14NaO5 261.0739; found 261.0742.
δ = 153.3 (CH, CH=CH–CO), 86.6 (CH, CHO), 47.0 (CH2), 44.6 Methyl 2-(Diethoxyphosphoryloxy)-6-(5-oxo-2,5-dihydrofuran-2-yl)-
(Cq, CCH2CH3), 28.5 (CH2), 26.7 (CH2) ppm; other signals
cyclohex-1-enecarboxylate (6a): This compound was prepared as
described in General Procedure C from the oxo ester 5a (32.6 mg,
0.136 mmol) in solution in THF (0.7 mL), NaH (60% in oil, 6 mg,
0.15 mmol) in suspension in THF (0.7 mL), and diethyl chloro-
masked by the major isomer. IR (film): ν = 3090, 2941, 2881, 1746,
˜
1702 cm–1. MS (ESI+): m/z (%) = 231 (100) [M + Na]. HRMS:
calcd. for C12H16NaO3 231.0997; found 231.0995.
Eur. J. Org. Chem. 2010, 5471–5481
© 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
5477